Sort by
Refine Your Search
-
focuses on investigating how biomedical implant degradation products modulate host immune responses using advanced cellular and murine models. The overarching goal is to develop novel therapeutic strategies
-
mouse model studies are needed for this position. Among the key duties of this position are the following: Treats and assesses mouse models of neurodegenerative disease using behavioral tests. Breeds
-
vary based on the position and may include: Medical, prescription drug, and dental coverage Paid vacation, holidays, and various leave programs Competitive retirement benefits, including defined
-
Overview RUTGERS CANCER INSTITUTE VISION, MISSION, AND CORE VALUES: VISION: Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused
-
(TurboID), phosphoproteomics, and mouse models (including bGHTg acromegaly mice and breast cancer xenografts), we aim to uncover fundamental mechanisms of IGF1R antagonism and develop peptide‑based
-
comprehensive benefits package to eligible employees. The specific benefits vary based on the position and may include: Medical, prescription drug, and dental coverage Paid vacation, holidays, and various leave
-
talent. Benefits Rutgers provides a comprehensive benefits package to eligible employees. The specific benefits vary based on the position and may include: Medical, prescription drug, and dental coverage
-
dopamine release in motor control. We are seeking self-motivated individuals with a strong background in synaptic biology, neuronal culture and live cell imaging to conduct quantitative analysis using novel
-
, receptor signaling assays, in vivo mouse models, and molecular or immunological techniques under the PI’s guidance. Meets with the principal investigator to establish goals and objectives for ongoing
-
Overview RUTGERS CANCER INSTITUTE VISION, MISSION, AND CORE VALUES: VISION: Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused